Stifel analyst Andreas Heine downgraded EMS-Chemie to Hold from Buy with a price target of CHF 700, down from CHF 810. The analyst expects a weak Q4 amid destocking and sees a lack of catalysts for the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly